CYTOMEGALOVIRUS (CMV)

Clinical trials for CYTOMEGALOVIRUS (CMV) explained in plain language.

Never miss a new study

Get alerted when new CYTOMEGALOVIRUS (CMV) trials appear

Sign up with your email to follow new studies for CYTOMEGALOVIRUS (CMV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 9 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

New trial aims to stop CMV eye inflammation from returning

Disease control Not yet recruiting

This study tests whether oral valganciclovir or ganciclovir eye drops can reduce the virus causing eye inflammation and prevent flare-ups. About 117 adults with CMV anterior uveitis will receive either antiviral treatment or placebo for 7 days, then some continue for 12 months. T…

Matched conditions: CYTOMEGALOVIRUS (CMV)

Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control

Last updated Aug 13, 2026 00:00 UTC

CYTOMEGALOVIRUS (CMV)

Get alerted when new CYTOMEGALOVIRUS (CMV) trials appear

New trial aims to stop CMV eye inflammation from returning